$NEO/USDT 4h (Binance Futures) Inverted Head & Shoulders retest
Neo seems to be preparing for next bullish move, after a clear retest of the iHnS neckline!
Also, we can see that 100EMA is supporting it so even more reason to enter a swing trade now.
Current Price= 39.780
Buy Entry= 39.752 - 39.152
Take Profit= 48.981 | 64.997 | 99.482
Stop Loss= 34.689
Risk/Reward= 1:2 | 1:5.36 | 1:12.6
Expected Profit= +48.30% | +129.50% | +304.32%
Possible Loss= -24.14%
Fib. Retracement= 0.786 | 1.272 | 2
Margin Leverage= 2x
Estimated Gain-time= 1 month
Also, we can see that 100EMA is supporting it so even more reason to enter a swing trade now.
Current Price= 39.780
Buy Entry= 39.752 - 39.152
Take Profit= 48.981 | 64.997 | 99.482
Stop Loss= 34.689
Risk/Reward= 1:2 | 1:5.36 | 1:12.6
Expected Profit= +48.30% | +129.50% | +304.32%
Possible Loss= -24.14%
Fib. Retracement= 0.786 | 1.272 | 2
Margin Leverage= 2x
Estimated Gain-time= 1 month
Trade active
All entries filledNeo had a pretty bad start but managed to break out of the triangle and to regain 100EMA support.
I think this trade could take way more time than I originally expected so I am taking some partial profit manually here!
Trade closed: target reached
🎯NNEO/USDT 4h: TP1 reached with +28.34% and +1.17R#Neo following my brush drawing nicely, we decided to lower the 3 targets since it's taking longer.
Risk/Reward ratios are still quite interesting, as shown in the chart!
Trade closed: target reached
TP3 reached with +129.50% and +5.36RAfter dipping back to buy zone, Neo pumped again stronger this time.
Original last target at 99.482$ is still likely to be reached for mid-term!
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.